RhumbLine Advisers’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $261K | Sell |
|
|||||
|
2025
Q2 | $229K | Sell |
|
|||||
|
2025
Q1 | $184K | Sell |
|
|||||
|
2024
Q4 | $359K | Buy |
|
|||||
|
2024
Q3 | $603K | Buy |
|
|||||
|
2024
Q2 | $491K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $78K | Sell |
|
|||||
|
2021
Q4 | $216K | Sell |
|
|||||
|
2021
Q3 | $328K | Sell |
|
|||||
|
2021
Q2 | $466K | Buy |
|
|||||
|
2021
Q1 | $433K | Sell |
|
|||||
|
2020
Q4 | $529K | Buy |
|
|||||
|
2020
Q3 | $409K | Sell |
|
|||||
|
2020
Q2 | $595K | Buy |
|